Inactief instrument

Andere talen Advanced Proteome Therapeutics Corp. Other OTC

Aandelen

CA0076281009

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Canadian Investment Regulatory Organization Trading Halt - APC.H	05/12
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	30-06-23
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	29-03-23
IIROC Trading Resumption - APC	17-01-23
IIROC Trading Halt - APC	17-01-23
Advanced Proteome Therapeutics Corporation agreed to Spin-Off Linceis Capital Corp.	17-01-23
Advanced Proteome Therapeutics Corporation announced that it has received CAD 0.0725 million in funding from Conation Capital	23-12-22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2022	21-12-22
Advanced Proteome Therapeutics Corporation Appoints Mr. Cory Brandolini to the Board of Directors	21-11-22
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	15-11-22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2022	15-11-22
ADVANCED PROTEOME THERAPEUTICS RECEIVES ISSUED PATENT	04-08-22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2022	28-06-22
Advanced Proteome Therapeutics up 28.5%, Receives Notice of Allowance for Patent Claims	13-04-22
Advanced Proteome Therapeutics Receives Notice of Allowance for Patent Claims	13-04-22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2022	25-03-22
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the First Quarter Ended October 31, 2021	17-12-21
Advanced Proteome Therapeutics Corporation Auditor Raises 'Going Concern' Doubt	29-11-21
Advanced Proteome Therapeutics Corporation Reports Earnings Results for the Full Year Ended July 31, 2021	29-11-21
Advanced Proteome Therapeutics Provides Update on COVID Program	24-08-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Advanced Proteome Therapeutics Corp. Other OTC

Aandelen

CA0076281009

Andere talen

Filters